Syverson Strege & CO Abbott Laboratories Transaction History

Syverson Strege & CO

$277 Million
Q3 2024

A detailed history of Syverson Strege & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Syverson Strege & CO holds 8,186 shares of ABT stock, worth $960,708. This represents 0.34% of its overall portfolio holdings.

Number of Shares

8,186

Previous 9,783 16.32%

Holding current value

$960,708

Previous $1.02 Million 8.17%

% of portfolio

0.34%

Previous 0.37%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $159,811 - $188,653	-1,597 Reduced 16.32%	8,186 $933,000
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $757,489 - $845,548	7,520 Added 332.3%	9,783 $1.02 Million
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $26,722 - $29,514	244 Added 12.09%	2,263 $257,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $182,093 - $222,897	2,019 New	2,019 $222,000
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $678 - $798	7 Added 0.39%	1,805 $182,000
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $570 - $669	6 Added 0.33%	1,798 $197,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $580 - $672	6 Added 0.34%	1,792 $173,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $510 - $616	5 Added 0.28%	1,786 $194,000
Q1 2022 Apr 13, 2022	BUY	$114.02 - $139.04 $684 - $834	6 Added 0.34%	1,781 $211,000
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $2,888 - $3,536	-25 Reduced 1.39%	1,775 $250,000
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $53,896 - $59,625	-462 Reduced 20.42%	1,800 $213,000
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $37,449 - $44,083	-354 Reduced 13.53%	2,262 $262,000
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $870 - $1,025	8 Added 0.31%	2,616 $314,000
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $273,840 - $298,407	2,608 New	2,608 $285,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

News

Stay updated on Syverson Strege & CO with notifications on news.

Account

Syverson Strege & CO Abbott Laboratories Transaction History